Form 4: Olesen Value Fund L.P. Reduces Stake in Solitron Devices Inc. (SODI)

Olesen Value Fund L.P. and related entities reported the sale of Solitron Devices Inc. shares over four days, reducing their holdings slightly.

Summary

• Olesen Value Fund L.P., along with Olesen Value Fund GP LLC, Olesen Capital Management LLC, and Christian Olesen, jointly filed a Form 4.
• The report details the sale of Solitron Devices Inc. (SODI) common stock, $0.01 par value, across multiple transactions from July 15, 2024, to July 18, 2024.
• A total of 1,000 shares were sold on July 15, 2024, at a price of $18.7 per share.
• On July 16, 2024, 600 shares were sold at $18.54 per share.
• An additional 125 shares were sold on July 17, 2024, at $18.74 per share.
• Finally, 175 shares were sold on July 18, 2024, at $18.74 per share.
• Following these transactions, the reporting persons collectively beneficially own 275,210 shares of SODI common stock.
• The reporting persons disclaim beneficial ownership of the shares except to the extent of their pecuniary interest.

Sentiment

Score: 5

Explanation: Neutral sentiment as it reports routine stock sales by a major shareholder. The sales are relatively small and don't necessarily indicate a strong positive or negative outlook.

Negatives

• Olesen Value Fund L.P. reduced its stake in Solitron Devices Inc.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or significant shareholders of a publicly traded company buy or sell the company's stock. These filings provide transparency into the transactions of those with privileged information.

Stakeholder Impact

• The sale of shares could have a minor impact on shareholder sentiment, but the relatively small volume suggests it's unlikely to cause significant concern.

Key Dates